|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:brand
|
gptkb:Inno_Pran_XL
gptkb:Inderal
|
|
gptkbp:category
|
Category C
Not recommended
|
|
gptkbp:class
|
gptkb:Magic:_The_Gathering_set
|
|
gptkbp:contraindication
|
Asthma
Heart block
Severe bradycardia
|
|
gptkbp:dosage_form
|
Extended-release tablet
Immediate-release tablet
|
|
gptkbp:duration
|
As prescribed by physician
|
|
gptkbp:effective_date
|
FDA approved
|
|
gptkbp:excretion
|
Urine
|
|
gptkbp:first_appearance
|
gptkb:High
|
|
gptkbp:formulation
|
gptkb:tablet
gptkb:item
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Inno Pran
|
|
gptkbp:indication
|
Performance anxiety
Migraine prophylaxis
Essential tremor
Thyroid storm
|
|
gptkbp:ingredients
|
gptkb:Propranolol
|
|
gptkbp:interacts_with
|
Calcium channel blockers
Antidepressants
Antiarrhythmics
|
|
gptkbp:is_atype_of
|
C07 A A05
|
|
gptkbp:is_monitored_by
|
Blood pressure
Heart rate
Renal function
Liver function
|
|
gptkbp:is_used_for
|
Hypertension
Angina
Heart attack prevention
|
|
gptkbp:lifespan
|
3 to 6 hours
|
|
gptkbp:manager
|
Oral
|
|
gptkbp:manufacturer
|
gptkb:Various
|
|
gptkbp:metabolism
|
Liver
|
|
gptkbp:side_effect
|
gptkb:Nausea
Dizziness
Fatigue
Sleep disturbances
|
|
gptkbp:social_structure
|
C16 H21 N O2
|
|
gptkbp:symptoms
|
gptkb:Tachycardia
Myocardial infarction
Angina
Rebound hypertension
|
|
gptkbp:bfsParent
|
gptkb:Propranolol
|
|
gptkbp:bfsLayer
|
6
|